SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ahhaha who wrote (921)7/12/1998 7:38:00 PM
From: Manny Gugliuzza  Read Replies (2) of 1510
 
Also we have to look at the fundamental side too.

What are the real negatives. Besides the RH product from Immunex recently announced Remune has got to sail or we drown.

The ability of the patients on the new 2x a day antiretrovrial drugs to have their immune systems bolstered without the help of Remune to the point where they can be removed from the drugs without increasing viral load.

None from the case studies.

Any others? take a hard look now. I think that is the majors

the only other neg in the tech sector are the those that want to sell their stock after buying on the way up from 15-19 and some of those that bought on the way down that will sell in the 15-17 area keeping downward pressure. for the amount of stock that exchanged hands on the way down, nearly 50% of the outstanding not including the sales from any conversion, it could be quite a bit of pressure.

investor sentiment will improve even with this drop as most of us long termers have come to except as "excess" only in light of non FDA approval as of yet and the absence of real earnings.

very few negatives mucho positives.

good luck with the buys down here

ar.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext